GLP-1 drugs: what Arkansas Medicaid paid

Q: Does a paid prescription mean Arkansas Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Arkansas Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Arkansas Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Arkansas Medicaid’s payment record shows

In 2026Q1, the product Arkansas Medicaid paid for most often was Victoza®, at 1,415 prescriptions³⁷ of the 4,387 to 4,621^{1,7,13,19,37,43} across all 8 products, or 32 percent of the published count.

Arkansas Medicaid itself reimbursed at least $3,526,300 for these products in the quarter, about $809 per prescription. Pharmacies were paid $3,539,518 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,315.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Arkansas Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Arkansas Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Arkansas Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Arkansas Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 24¹	<1%	$25,044	$26,027	$1,044
tirzepatideMounjaro®	Both202 managed care, 594 direct	796⁷	18%	$857,618	$862,715	$1,077
semaglutideWegovy®	Fee-for-service	at least 103¹³	2%	$135,496	$135,496	$1,315
semaglutideOzempic®	Both237 managed care, 1,073 direct	1,310¹⁹	30%	$1,305,746	$1,312,884	$997
semaglutideRybelsus®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both119 managed care, 1,296 direct	1,415³⁷	32%	$918,108	$918,108	$649
liraglutideliraglutide (generic)	Both70 managed care, 643 direct	at least 713⁴³	16%	$284,288	$284,288	$399

Arkansas Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were higher in 2026Q1 than in 2021Q1: 1,415 against 1,042. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 6.1 to 6.4 prescriptions per thousand people enrolled in Arkansas Medicaid, on an average of 717,884 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 34 of the 168 product-quarters it holds a row for here, which is 20 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Victoza® carries a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Arkansas Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Arkansas Medicaid paid for each product, quarter by quarter

Prescriptions Arkansas Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable²Withheld7 of 7 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable²Withheld11 of 11 product codes withheld	at least 24 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$25,044 paid
tirzepatideMounjaro®range 470 to 796, up 160 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	at least 28 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$26,906 paid	at least 12 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$12,041 paid	at least 45 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$45,676 paid	at least 59 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$60,057 paid	at least 62 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$62,733 paid	at least 95 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$99,137 paid	at least 137 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$143,804 paid	at least 199 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$209,084 paid	at least 260 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$272,754 paid	at least 323 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$342,256 paid	at least 444 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$469,768 paid	470 paid prescriptions in the quarter (2025Q3)⁸Count$498,640 paid	636 paid prescriptions in the quarter (2025Q4)⁸Count$673,442 paid	796 paid prescriptions in the quarter (2026Q1)⁷Count$857,618 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable¹⁵Withheld7 of 7 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable¹⁴Withheld8 of 8 product codes withheld	at least 42 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$55,083 paid	at least 63 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$82,715 paid	at least 80 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$105,162 paid	at least 103 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$135,496 paid
semaglutideOzempic®range 306 to 1,310, up 147 on the quarter before	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable²⁴Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable²⁴Withheld4 of 4 product codes withheld	at least 13 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$10,949 paid	at least 28 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$23,654 paid	at least 42 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$36,686 paid	at least 53 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$45,741 paid	at least 97 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$84,126 paid	at least 119 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$104,029 paid	at least 143 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$129,501 paid	at least 230 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$208,955 paid	306 paid prescriptions in the quarter (2023Q3)²²Count$277,200 paid	325 paid prescriptions in the quarter (2023Q4)²²Count$295,324 paid	431 paid prescriptions in the quarter (2024Q1)²¹Count$401,868 paid	510 paid prescriptions in the quarter (2024Q2)²¹Count$480,360 paid	649 paid prescriptions in the quarter (2024Q3)²¹Count$609,673 paid	754 paid prescriptions in the quarter (2024Q4)²¹Count$708,891 paid	950 paid prescriptions in the quarter (2025Q1)²⁰Count$918,181 paid	1,182 paid prescriptions in the quarter (2025Q2)²⁰Count$1,151,448 paid	1,216 paid prescriptions in the quarter (2025Q3)²⁰Count$1,188,151 paid	1,163 paid prescriptions in the quarter (2025Q4)²⁰Count$1,135,496 paid	1,310 paid prescriptions in the quarter (2026Q1)¹⁹Count$1,305,746 paid
semaglutideRybelsus®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁰Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable³⁰Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁰Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁰Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable²⁹Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable²⁹Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable²⁹Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable²⁹Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable²⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable²⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable²⁸Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable²⁸Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable²⁷Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable²⁷Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable²⁷Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable²⁷Withheld6 of 6 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²⁶Withheld6 of 6 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²⁶Withheld6 of 6 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable²⁶Withheld6 of 6 product codes withheld	at least 11 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$10,887 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable²⁵Withheld6 of 6 product codes withheld
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 506 to 3,948, up 459 on the quarter before	1,042 paid prescriptions in the quarter (2021Q1)⁴²Count$836,731 paid	1,273 paid prescriptions in the quarter (2021Q2)⁴²Count$1,038,462 paid	1,539 paid prescriptions in the quarter (2021Q3)⁴²Count$1,261,266 paid	1,626 paid prescriptions in the quarter (2021Q4)⁴²Count$1,339,515 paid	1,957 paid prescriptions in the quarter (2022Q1)⁴¹Count$1,657,322 paid	2,227 paid prescriptions in the quarter (2022Q2)⁴¹Count$1,917,739 paid	2,297 paid prescriptions in the quarter (2022Q3)⁴¹Count$2,007,808 paid	2,568 paid prescriptions in the quarter (2022Q4)⁴¹Count$2,232,152 paid	3,225 paid prescriptions in the quarter (2023Q1)⁴⁰Count$2,890,138 paid	3,912 paid prescriptions in the quarter (2023Q2)⁴⁰Count$3,504,167 paid	3,948 paid prescriptions in the quarter (2023Q3)⁴⁰Count$3,535,838 paid	3,791 paid prescriptions in the quarter (2023Q4)⁴⁰Count$3,426,774 paid	3,504 paid prescriptions in the quarter (2024Q1)³⁹Count$2,547,634 paid	3,475 paid prescriptions in the quarter (2024Q2)³⁹Count$2,306,989 paid	3,189 paid prescriptions in the quarter (2024Q3)³⁹Count$2,084,784 paid	3,225 paid prescriptions in the quarter (2024Q4)³⁹Count$2,189,693 paid	1,628 paid prescriptions in the quarter (2025Q1)³⁸Count$983,538 paid	506 paid prescriptions in the quarter (2025Q2)³⁸Count$335,370 paid	771 paid prescriptions in the quarter (2025Q3)³⁸Count$497,263 paid	956 paid prescriptions in the quarter (2025Q4)³⁸Count$637,752 paid	1,415 paid prescriptions in the quarter (2026Q1)³⁷Count$918,108 paid
liraglutideliraglutide (generic)range 211 to 1,217	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 205 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$126,823 paid	211 paid prescriptions in the quarter (2024Q4)⁴⁵Count$118,187 paid	1,217 paid prescriptions in the quarter (2025Q1)⁴⁴Count$710,297 paid	at least 2,495 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$1,263,827 paid	at least 1,971 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$922,881 paid	at least 1,337 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$598,725 paid	at least 713 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$284,288 paid

What this page cannot tell you

Whether Arkansas Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Arkansas in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, AR
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state AR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "13"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, AR
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state AR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, AR
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state AR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like ZEPBOUND%, state AR, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, AR
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state AR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like ZEPBOUND%, state AR, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, AR
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state AR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like ZEPBOUND%, state AR, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, AR
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state AR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like ZEPBOUND%, state AR, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, AR
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state AR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AR", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "152"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, AR
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state AR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "104"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, AR
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state AR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "32"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, AR
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state AR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "36"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, AR
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state AR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, AR
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state AR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like MOUNJARO%, state AR, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, AR
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state AR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AR", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "42"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, AR
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state AR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "30"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, AR
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state AR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, AR
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state AR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like WEGOVY%, state AR, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, AR
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state AR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like WEGOVY%, state AR, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, AR
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state AR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like WEGOVY%, state AR, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, AR
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state AR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AR", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "445"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, AR
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state AR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "382"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, AR
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state AR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "212"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, AR
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state AR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "98"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, AR
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state AR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "37"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, AR
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state AR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "17"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, AR
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state AR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, AR
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state AR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, AR
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state AR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, AR
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state AR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, AR
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state AR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, AR
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state AR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, AR
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state AR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like SAXENDA%, state AR, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, AR
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state AR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, AR
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state AR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like SAXENDA%, state AR, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, AR
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state AR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, AR
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state AR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like SAXENDA%, state AR, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, AR
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state AR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like SAXENDA%, state AR, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, AR
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state AR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AR", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "649"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, AR
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state AR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "1031"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, AR
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state AR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1818"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, AR
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state AR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1804"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, AR
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state AR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1230"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, AR
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state AR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "756"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, AR
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state AR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AR", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "174"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, AR
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state AR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "883"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, AR
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state AR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "112"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, AR
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state AR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like LIRAGLUTID%, state AR, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, AR
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state AR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like LIRAGLUTID%, state AR, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, AR
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state AR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AR", "product_name": "product_name like LIRAGLUTID%, state AR, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 33 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 15 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Arkansas Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.